Comparison Chart Basilea Pharmaceutica AG

Stocks

BSLN

CH0011432447

Biotechnology & Medical Research

Market Closed - Swiss Exchange 10:00:15 06/11/2026 pm IST			5-day change	1st Jan Change
71.00 ^CHF	-0.56%		+0.28%	+29.80%

03/11	Basilea Pharmaceutica Gets $38 Million in Milestone Payment for Cresemba Sales in Europe	MT
03/11	Strong Cresemba(R) (isavuconazole) sales in Europe trigger USD 37.5 million milestone payment to Basilea	DJ

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	BASILEA PHARMACEUTICA AG	Other Biotechnology & Medical Research	-0.56%	+0.28%	+29.80%	+57.60%	+65.73%	107.63Cr